A detailed history of Bank Of New York Mellon Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Bank Of New York Mellon Corp holds 13,562,399 shares of ABT stock, worth $1.55 Billion. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,562,399
Previous 14,155,518 4.19%
Holding current value
$1.55 Billion
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$100.07 - $118.13 $59.4 Million - $70.1 Million
-593,119 Reduced 4.19%
13,562,399 $0
Q2 2024

Jul 25, 2024

SELL
$100.73 - $112.44 $60.6 Million - $67.7 Million
-601,958 Reduced 4.08%
14,155,518 $0
Q1 2024

Apr 25, 2024

SELL
$109.52 - $120.96 $39.6 Million - $43.7 Million
-361,452 Reduced 2.39%
14,757,476 $0
Q4 2023

Jan 29, 2024

BUY
$90.19 - $110.4 $46.5 Million - $57 Million
515,925 Added 3.53%
15,118,928 $0
Q3 2023

Oct 24, 2023

SELL
$95.53 - $114.62 $54.4 Million - $65.2 Million
-569,235 Reduced 3.75%
14,603,003 $0
Q2 2023

Aug 03, 2023

SELL
$100.78 - $112.29 $124 Million - $138 Million
-1,232,782 Reduced 7.51%
15,172,238 $0
Q1 2023

May 09, 2023

BUY
$96.86 - $114.01 $1.59 Billion - $1.87 Billion
16,405,020 New
16,405,020 $0
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $1.72 Billion - $2.01 Billion
18,044,765 New
18,044,765 $1.98 Billion
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $93.6 Million - $108 Million
-967,060 Reduced 5.04%
18,215,609 $1.76 Billion
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $11.1 Million - $13.4 Million
-108,309 Reduced 0.56%
19,182,669 $2.08 Billion
Q1 2022

May 11, 2022

SELL
$114.02 - $139.04 $232 Million - $283 Million
-2,035,995 Reduced 9.55%
19,290,978 $2.28 Billion
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $84.1 Million - $103 Million
727,906 Added 3.53%
21,326,973 $3 Billion
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $50.2 Million - $55.5 Million
-430,106 Reduced 2.05%
20,599,067 $2.43 Billion
Q2 2021

Aug 11, 2021

SELL
$105.79 - $124.53 $61.3 Million - $72.2 Million
-579,604 Reduced 2.68%
21,029,173 $2.44 Billion
Q1 2021

May 13, 2021

BUY
$108.84 - $128.23 $31.1 Million - $36.7 Million
285,822 Added 1.34%
21,608,777 $2.59 Billion
Q4 2020

Feb 09, 2021

BUY
$105.0 - $114.42 $60.1 Million - $65.5 Million
572,841 Added 2.76%
21,322,955 $2.33 Billion
Q3 2020

Nov 12, 2020

BUY
$91.64 - $111.29 $21.2 Million - $25.8 Million
231,496 Added 1.13%
20,750,114 $2.26 Billion
Q2 2020

Aug 12, 2020

SELL
$76.57 - $98.0 $34.2 Million - $43.7 Million
-446,101 Reduced 2.13%
20,518,618 $1.88 Billion
Q1 2020

May 06, 2020

BUY
$62.82 - $91.86 $9.8 Million - $14.3 Million
156,076 Added 0.75%
20,964,719 $1.65 Billion
Q4 2019

Feb 14, 2020

SELL
$78.51 - $87.4 $58.2 Million - $64.8 Million
-741,102 Reduced 3.44%
20,808,643 $1.81 Billion
Q3 2019

Nov 07, 2019

SELL
$81.84 - $88.74 $44 Million - $47.7 Million
-537,124 Reduced 2.43%
21,549,745 $1.8 Billion
Q2 2019

Aug 12, 2019

SELL
$72.88 - $85.0 $108 Million - $126 Million
-1,486,126 Reduced 6.3%
22,086,869 $1.86 Billion
Q1 2019

May 14, 2019

SELL
$66.22 - $80.06 $52.2 Million - $63.2 Million
-788,814 Reduced 3.24%
23,572,995 $1.88 Billion
Q4 2018

Feb 11, 2019

SELL
$65.56 - $74.27 $188 Million - $213 Million
-2,872,949 Reduced 10.55%
24,361,809 $1.76 Billion
Q3 2018

Nov 09, 2018

BUY
$60.81 - $73.36 $1.65 Billion - $2 Billion
27,208,125 Added 102159.45%
27,234,758 $0
Q2 2018

Aug 24, 2018

SELL
$57.57 - $63.54 $1.66 Billion - $1.84 Billion
-28,881,567 Reduced 99.91%
26,633 $1.63 Million
Q2 2018

Aug 06, 2018

SELL
$57.57 - $63.54 $51.6 Million - $57 Million
-896,354 Reduced 3.01%
28,908,200 $1.76 Billion
Q1 2018

May 15, 2018

SELL
$56.27 - $63.62 $87.6 Million - $99 Million
-1,556,176 Reduced 4.96%
29,804,554 $1.79 Billion
Q4 2017

Feb 09, 2018

BUY
$53.68 - $57.47 $1.68 Billion - $1.8 Billion
31,360,730
31,360,730 $1.79 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.